Cytonics
Blood & Organ Banks · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
658 W Indiantown Rd Ste 214, Jupiter, Fl...Phone Number
(561) 406-2864Website
www.cytonics.comRevenue
<$5 MillionIndustry
About Cytonics
Cytonics Corporation is a clinical-stage biotechnology company focused on developing innovative treatments for osteoarthritis, the most common joint disease. Utilizing Alpha-2-Macroglobulin (A2M), Cytonics has created a novel biologic, CYT-108, which aims to target the molecular causes of cartilage degradation and potentially reverse osteoarthritis progression. The company seeks to provide effective therapies where traditional medications have failed, emphasizing a patient-centered approach. Cytonics is committed to pioneering drug discovery and addressing the shortcomings of existing pharmaceutical solutions.Explore more
SIC Code 28,283NAICS Code 32,325Show moreCytonics Org Chart
Compare Similar Companies to Cytonics
Compare insights from companies similar to Cytonics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cytonics Tech Stack
A closer look at the technologies used by Cytonics
See more technologies
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Cytonics
Sign Up For FreeTo access detailed company insights
Cytonics Corporation is a clinical-stage biotechnology company focused on developing innovative treatments for osteoarthritis, the most common joint disease. Utilizing Alpha-2-Macroglobulin (A2M), Cytonics has created a novel biologic, CYT-108, which aims to target the molecular causes of cartilage degradation and potentially reverse osteoarthritis... Read More